(ICORG 05-03): prospective randomized non-inferiority phase III trial comparing two radiation schedules in malignant spinal cord compression (not proceeding with surgical decompression); the quality of life analysis

被引:21
作者
Lee, K. A. [1 ]
Dunne, M. [2 ]
Small, C. [3 ]
Kelly, P. J. [4 ]
McArdle, O. [1 ]
O'Sullivan, J. [5 ]
Hacking, D. [6 ]
Pomeroy, M. [3 ]
Armstrong, J. [1 ]
Moriarty, M. [1 ]
Clayton-Lea, A. [7 ]
Parker, I [8 ]
Collins, C. D. [9 ]
Thirion, P. [1 ]
机构
[1] St Lukes Radiat Oncol Network, Radiat Oncol Dept, Dublin, Ireland
[2] St Lukes Radiat Oncol Network, Clin Trials Unit, Dublin, Ireland
[3] Galway Univ Hosp, Radiat Oncol Dept, Galway, Ireland
[4] Cork Univ Hosp, Radiat Oncol Dept, Cork, Ireland
[5] Belfast City Hosp, Radiat Oncol Dept, Belfast, Antrim, North Ireland
[6] Whitfield Clin, Radiat Oncol Dept, Waterford, Ireland
[7] St Lukes Radiat Oncol Network, Operat Serv, Dublin, Ireland
[8] All Ireland Cooperat Oncol Res Grp, Radiat Oncol Dept, Dublin, Ireland
[9] St Lukes Radiat Oncol Network, Radiol Dept, Dublin, Ireland
关键词
CANCER CARE; RADIOTHERAPY; DIAGNOSIS; SURVIVAL; END;
D O I
10.1080/0284186X.2018.1433320
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The optimal primary external beam radiation therapy (EBRT) radiation schedule for malignant epidural spinal cord compression (MSCC) remains to be determined. The ICORG 05-03 trial assessed if a 10Gy single fraction radiation schedule was not inferior to one with 20 Gray (Gy) in five daily fractions, in terms of functional motor outcome, for the treatment of MSCC in patients not proceeding with surgical decompression. This article reports on two of the secondary endpoints, Quality of life (QoL), assessed according to the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 (QLQ-C30) version 3.0 (EORTC Data Center, Brussels, Belgium) and pain control assessed using a visual analog scale. Methods: A randomized, parallel group, multicenter phase III trial was conducted by Cancer Trials Ireland (formerly All-Ireland Cooperative Oncology Research Group, ICORG), across five hospital sites in Ireland and Northern Ireland. Patients were randomized to 10Gy single fraction of EBRT or 20Gy in five fractions in a 1:1 ratio. Patients with baseline and 5-week follow up QoL data are included in this analysis. Findings: From 2006 to 2014, 112 eligible patients were enrolled for whom 57 were evaluated for this secondary analysis. After adjusting for pre-intervention scores, there was no statistically significant difference in post-treatment Summary scores (excl. Fl and QL), or pain scores between the two RT schedules at 5 weeks and 3 months following EBRT. There was a statistically significant relationship between the pretreatment and post-treatment Summary scores (p = .002) but not between the pre-treatment and post-treatment pain scores. Interpretation: Primary radiotherapy for the treatment of MSCC significantly improves QoL in patients not proceeding with surgical decompression. After adjusting for pre-intervention scores, there was no statistically significant difference between a 10Gy single fraction radiation schedule and one with 20Gy in five daily fractions on post-treatment QoL Summary scores. For most patients, an effective treatment with low burden would be desirable. A single fraction schedule should be considered for this group of patients.
引用
收藏
页码:965 / 972
页数:8
相关论文
共 29 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   Pre- and post-treatment daily life function in patients with hormone resistant prostate carcinoma treated with radiotherapy for spinal cord compression [J].
Aass, N ;
Fosså, SD .
RADIOTHERAPY AND ONCOLOGY, 2005, 74 (03) :259-265
[3]  
[Anonymous], COCHRANE DATABASE SY
[4]   A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients [J].
Bjordal, K ;
de Graeff, A ;
Fayers, PM ;
Hammerlid, E ;
van Pottelsberghe, C ;
Curran, D ;
Ahlner-Elmqvist, M ;
Maher, EJ ;
Meyza, JW ;
Brédart, A ;
Söderholm, AL ;
Arraras, JJ ;
Feine, JS ;
Abendstein, H ;
Morton, RP ;
Pignon, T ;
Huguenin, P ;
Bottomly, A ;
Kaasa, S .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (14) :1796-1807
[5]   Palliative radiotherapy trials for bone metastases: A systematic review [J].
Chow, Edward ;
Harris, Kristin ;
Fan, Grace ;
Tsao, May ;
Sze, Wai M. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (11) :1423-1436
[6]   Identifying potential indicators of the quality of end-of-life cancer care from administrative data [J].
Earle, CC ;
Park, ER ;
Lai, B ;
Weeks, JC ;
Ayanian, JZ ;
Block, S .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (06) :1133-1138
[7]   Aggressiveness of cancer care near the end of life: Is it a quality-of-care issue? [J].
Earle, Craig C. ;
Landrum, Mary Beth ;
Souza, Jeffrey M. ;
Neville, Bridget A. ;
Weeks, Jane C. ;
Ayanian, John Z. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (23) :3860-3866
[8]   Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust [J].
Giesinger, Johannes M. ;
Kieffer, Jacobien M. ;
Fayers, Peter M. ;
Groenvold, Mogens ;
Petersen, Morten Aa. ;
Scott, Neil W. ;
Sprangers, Mirjam A. G. ;
Velikova, Galina ;
Aaronson, Neil K. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2016, 69 :79-88
[9]   EPIDURAL SPINAL-CORD COMPRESSION FROM METASTATIC TUMOR - DIAGNOSIS AND TREATMENT [J].
GILBERT, RW ;
KIM, JH ;
POSNER, JB .
ANNALS OF NEUROLOGY, 1978, 3 (01) :40-51
[10]   The development of the EORTC QLQ-C15-PAL: A shortened questionnaire for cancer patients in palliative care [J].
Groenvold, M ;
Petersen, MA ;
Aaronson, NK ;
Arraras, JI ;
Blazeby, JM ;
Bottomley, A ;
Fayers, PM ;
de Graeff, A ;
Hammerlid, E ;
Kaasa, S ;
Sprangers, MAG ;
Bjorner, JB .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (01) :55-64